ARTICLE | Company News
Curis, LLS deal
October 29, 2012 7:00 AM UTC
Curis received two milestone payments totalling $750,000 from the society under a 2011 deal to develop Curis' CUDC-907 in B cell lymphoma and multiple myeloma (MM). The payments were triggered by the...